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Abstract
Background: Sequencing based mutation screening
assays of genes encompassing large numbers of
exons could be substantially optimized by multiplex
PCR, which enables simultaneous amplification of
many targets in one reaction. In the present study, a
multiplex PCR protocol originally developed for frag-
ment analysis was evaluated for sequencing based
mutation screening of the ornithine transcarbamylase
(OTC) and the medium-chain acyl-CoA dehydrogen-
ase (MCAD) genes.
Methods: Single exon and multiplex PCR protocols
were applied to generate PCR templates for subse-
quent DNA sequencing of all exons of the OTC and
the MCAD genes. For each PCR protocol and using
the same DNA samples, 66 OTC and 98 MCAD
sequence reads were generated. The sequences
derived from the two different PCR methods were
compared at the level of individual signal-to-noise
ratios of the four bases and the proportion of high-
quality base-signals.
Results: The single exon and the multiplex PCR pro-
tocol gave qualitatively comparable results for the
two genes.
Conclusions: Many existing sequencing based muta-
tion analysis protocols may be easily optimized with
the proposed method, since the multiplex PCR pro-
tocol was successfully applied without any re-design
of the PCR primers and other optimization steps for
generating sequencing templates for the OTC and
MCAD genes, respectively.
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Multiplex PCR is a variant of PCR enabling simul-
taneous amplification of many targets of interest in
one reaction by using more than one pair of primers.
Although the advantage of this technique is obvious
in optimizing sequencing based mutation screening
assays of genes encompassing a large number of
exons, only very few such assays have been devel-
oped so far. This is mainly because multiplex assays
have generally been tedious and time-consuming to
establish, requiring lengthy optimization procedures.
DNA sequencing is a gold standard for screening
for known and unknown disease causing mutations
in many genes, such as the medium-chain acyl-CoA
dehydrogenase (MCAD; RefSeq: NM_000016.2) and
the ornithine transcarbamylase (OTC; RefSeq:
NM_000531.3). The so-far known mutations are dis-
tributed over all exons of these genes, and there are
no mutation detection kits available. Until now, all
exons of these genes have been screened for muta-
tions with a rather time-consuming procedure con-
sisting of single-exon PCR-amplification, purification,
and sequencing.
MCAD catalyzes the b-oxidation of fatty acids,
whereas OTC is an enzyme of the urea cycle and
catalyzes the formation of citrulline and inorganic
phosphate from carbamyl phosphate and ornithine.
Mutations in these genes may result in deficient
enzymes, which in the case of MCAD deficiency can
result in catabolic stress with some patients dying due
to catastrophic neurological damage during decom-
pensation with hypoketotic hypoglycemia (1). OTC
deficiency is the most frequently inherited defect of
the urea cycle and has an estimated prevalence of one
in 14,000 (2). Complete OTC deficiency results in
acute hyperammonemia in the first year of life and as
a consequence has toxic effects on the brain. In
severe cases, hyperammonemia can result in coma,
brain edema, and death due to vascular compromise
or brain herniation. MCAD is located on chromosome
1p31 and is encoded by 12 exons separated by 11
introns, and the gene coding for OTC is located on
the short arm of chromosome X, spans 73 kb and con-
tains 10 exons and nine introns. So far, 72 mutations
have been described in the MCAD gene (www.
hgmd.cf.ac.uk), also 341 mutations and 29 non-dis-
ease-causing mutations and polymorphisms have
been described in the OTC gene wreviewed in ref. (2)x.
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Table 1 Composition of primer mixes for MCAD and OTC
multiplex PCR reactions.
MCAD mix Exon  Fragment length (bp)
1 1 372
2 300
3/4 426
9 347
2 5 319
6 351
10 293
12 441
3 7 315
8 291
11 435
OTC mix Exon  Fragment length (bp)
1 1 294
3 223
5 272
7 183
9 280
2 2 246
4 223
6 213
8 282
10 267
Screening for mutations in the genes encoding for
MCAD or OTC is applied early in life, when symptoms
of metabolic disorders are diagnosed. In addition, if
familiar history is known, mutation screening is often
applied as a prenatal molecular diagnostic test based
on chorionic villi sampling.
Here, we describe a rapid and reliable method for
generating templates for the sequencing of all exons
of the OTC and MCAD genes, respectively. This meth-
od is based on multiplex PCR reactions using the
same primers as for the amplification of single exons
(Table 1). For evaluation of the multiplex PCR, we
sequenced the PCR products of all exons from both
genes with DNA samples from three or five donors,
respectively. The quality of these sequences was
compared with results obtained from validated stan-
dard protocols based on single-exon PCR, used in our
laboratory for routine diagnostics.
To reduce the workload and risk of (pipetting-)
errors, primer master-mixes containing forward and
reverse primers of single exons according to Table 1
were prepared. Once tested, these master-mixes were
used in multiplex PCR for the amplification of the dif-
ferent exons serving as sequencing templates. Even
though the set-up of multiplex PCR reactions might
be very difficult (3), we were successful in setting up
multiplex PCR reactions, as shown in Figure 1. In the
multiplex PCR for MCAD (Figure 1A) or OTC (Figure
1B), the same amplicons were detectable as in the
single-exon PCR amplifications. The individual
sequences derived from the two different PCR meth-
ods were compared at the level of individual signal-
to-noise (S/N) ratios of the four bases A, C, G, and T,
as well as the proportion of high-quality ()99% con-
fidence scores obtained with KB base caller software;
Applied Biosystems, Rotkreuz, Switzerland) base-
signals.
For the amplification of single exons, PCR reactions
were performed in hot-start wax tubes. Lower reac-
tion mixtures were prepared containing 10= PCR
bufferqMg2q, PCR nucleotide mix, and forward and
reverse primers (each 10 mM). Upper mixes were pre-
pared containing 1.85 U high-fidelity Taq polymerase
(Roche Diagnostics, Rotkreuz, Switzerland), 10= PCR
bufferqMg2q. Finally, 200 ng template DNA was add-
ed to each reaction. PCR reactions were conducted as
follows: denaturation at 948C for 5 min (MCAD exon
1, 968C); 35 cycles at 948C for 30 s, annealing for 60 s,
and at 728C for 90 s; final extension at 728C for 5 min;
annealing temperatures were 608C for MCAD exon 1,
578C for MCAD exons 2–12, and 558C for all OTC
exons.
For the amplification of the exons in multiplex PCR
set-up, all reactions were performed with a multiplex
PCR kit (Qiagen, Hombrechtikon, Switzerland, Cat
206143). Reaction mixtures were prepared containing
12.5 mL 2= multiplex master mix, 2.5 mL 10= primer
mix (according to Table 1, each primer 2 mM), 2.5 mL
Q-solution, 4.5 mL molecular grade water, and 3 mL
genomic DNA as template (up to 300 ng). PCR reac-
tions were conducted as follows: denaturation at 958C
for 15 min; 35 cycles at 948C for 30 s, 578C (MCAD) or
558C (OTC) for 90 s, and 728C for 60 s; final extension
at 728C for 10 min. A 5-mL aliquot of the PCR products
was analyzed on 1.5% agarose gel to verify the size
of all products (Figure 1A and B).
For sequencing, all PCR products (single exon reac-
tions or multiplex reactions) were directly purified
with a PCR purification kit (Qiagen, Cat 28106). Indi-
vidual PCR products of the multiplex PCR reactions
were not separated for sequencing, thus themultiplex
PCR products containing up to five different ampli-
cons were directly used as templates for sequencing.
For cycle sequencing, reaction mixtures were pre-
pared as follows: 3.5 mL 2.5= sequencing buffer,
0.5 mL ready reaction mix (both from BigDye Termi-
nator v3.1 cycle sequencing kit; Applied Biosystems,
Cat 4336917), 1 mL primer (5 mM), PCR product
(20–30 ng), and molecular grade water up to 10 mL
final volume. Cycle sequencing conditions were:
denaturation at 968C for 60 s, 25 cycles at 968C for
10 s, at 508C for 5 s, and 608C for 75 s. Each cycle
sequencing reaction was supplemented by 10 mL
molecular grade water and 2 mL 2.2% sodium dodecyl
sulfate and was denatured for 5 min at 988C. After
purification on DyeEx columns (Qiagen, Cat 63206),
sequences were separated on ABI3130XL using POP7
polymer on a 50-cm array, acquired using sequence
detection software v.3.0 and analyzed with sequence
analysis software v.5.2 (all from Applied Biosystems).
A total of 66 MCAD sequences (3 donors, 11 PCR
products, forward and reverse sequences) obtained
from multiplex PCR were compared with the corre-
sponding sequences obtained from single-exon PCR.
Out of 66 sequences, 56 derived from multiplex PCR
products had higher S/N ratios than the correspond-
ing single-exon PCR derived sequences. The propor-
tion of high-quality ()99%) signals of the multiplex
PCR derived sequences was significantly higher than
that of the single-exon sequences (97.73%"1.8% vs.
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Figure 1 Gel-electrophoresis analyses of multiplex PCR and single-exon PCR.
PCR products were separated on 1.5% agarose gels, stained with ethidium bromide. (A) Multiplex PCR mixes 1–3 of MCAD
(left) and single-exon PCR products 1–12 (right), as indicated. Fragment sizes of a 100-bp DNA ladder (M) are indicated. The
fragment lengths of the PCR products are listed in Table 1. (B) Multiplex PCR mixes 1 and 2 of OTC (left) and single-exon
PCR products 1–10 (right), as indicated. (C) Screenshot of a multiplex PCR derived sequence. Upper panel, forward sequence;
lower panel, reverse sequence; the heterozygous mutation is indicated by an arrow.
95.92%"3.8%; p-0.0001; non-parametric two-tailed
signed-rank Wilcoxon test). The range of the propor-
tion of high-quality signals was 91.14%–100% for
multiplex sequences, and 76.9%–99.52% for single-
exon sequences, respectively. In the case of MCAD
analysis, the switch to multiplex PCR did not only
facilitate the experimental work process, but also
even more importantly, improved the sequence
quality.
In contrast to these results, only 16 out of a total of
98 sequences derived from multiplex PCR of the OTC
exons had equal or higher S/N ratios than the corre-
sponding single-exon derived sequences. A total of 98
OTC sequences (5 donors, 10 exons, forward and
reverse, except exon 1, only 3 donors) generated by
multiplex and single-exon PCR, respectively, were
included in this analysis. Even though the proportion
of high-quality scores of the multiplex PCR derived
sequences was slightly lower (94.32%"3.3% vs.
94.87%"4.8%; ps0.017; non-parametric two-tailed
signed-rank Wilcoxon test), the diagnostic power of
this test was not affected. First, the mutations bearing
a phenotypic consequence are not located at the
beginning or the end of the amplicons, where some
ambiguous bases might occur in the multiplex
sequences. Secondly, these analyses are based on
genomic DNA, thus all mutations are either homozy-
gous (in males) or heterozygous (females), and in the
latter case the bases of both alleles are represented
with equal signal strength (Figure 1C).
Even though the improvement of signal quality can-
not always be achieved, the switch from single-exon
PCR to multiplex PCR is still reasonable, as I) the
workload and costs of PCR and purification of PCR
products are markedly reduced, and II) the risk of
pipetting errors is reduced, as primer master mixes
can be prepared. Once tested, these master mixes can
be stored in aliquots for several months. In emergen-
cy cases, as is often the case, when newborns show
symptoms of MCAD or OTC deficiency, the sequence
analysis of all exons might be performed in less than
48 h, including DNA extraction, multiplex PCR, cycle
sequencing and sequence analysis. Furthermore, it is
worth mentioning that a higher degree of multiplex-
ing may be achieved for these two genes using the
proposed protocol even without re-designing primer
pairs. However, the combinations of exons in the dif-
ferent PCR reactions were chosen to allow a visual
control of the PCR amplification by agarose gel elec-
trophoresis (Figure 1A and B).
Because we have not made any specific re-design
of the PCR primers for multiplexing of the OTC and
MCAD genes and because we could successfully
apply a standard PCR protocol to both genes without
any optimization steps, we suggest that many exist-
ing sequencing based mutation analysis protocols
could be easily optimized with the proposed method
for many other genes, in which the mutations –
known and so-far unknown – can be distributed over
the whole genes. Indeed, we successfully established
multiplex PCR using the described protocol for muta-
tion screening by DNA sequencing in the proto-onco-
gene p53, as well as other multi-exon genes, not
reported here.
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